These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 4583148)

  • 21. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperacute rejection of renal allografts in the primate: protective effect of F(ab') 2 fragment of hyperimmune serum.
    Kobayashi K; Hricko GM; Habal MB; Lukl P; Busch GJ; Hunsicker L; Reisner GS; Birtch AG
    Transplantation; 1972 Sep; 14(3):374-81. PubMed ID: 4629283
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative studies on antigenic recognition. IV. Specific inhibition of the recognition process by alloantisera.
    Ramseier H; Lindenmann J
    Eur J Immunol; 1971 Dec; 1(6):441-6. PubMed ID: 4112253
    [No Abstract]   [Full Text] [Related]  

  • 24. Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts.
    Xu R; Burdick JF; Scott A; Beschorner WE; Adler W; Kittur DS
    Immunology; 1992 Feb; 75(2):361-5. PubMed ID: 1551698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological enhancement of skin grafts in the mouse.
    Jeekel JJ; McKenzie IF; Winn HJ
    J Immunol; 1972 Apr; 108(4):1017-24. PubMed ID: 4112414
    [No Abstract]   [Full Text] [Related]  

  • 26. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the H-2 gene dose on the rejection of skin grafts.
    McKenzie IF
    Transplantation; 1973 Jun; 15(6):555-63. PubMed ID: 4123701
    [No Abstract]   [Full Text] [Related]  

  • 28. Allogeneic fibroblasts used to grow cultured epidermal autografts persist in vivo and sensitize the graft recipient for accelerated second-set rejection.
    Hultman CS; Brinson GM; Siltharm S; deSerres S; Cairns BA; Peterson HD; Meyer AA
    J Trauma; 1996 Jul; 41(1):51-8; discussion 58-60. PubMed ID: 8676424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A further study on the genetic rules of transplantation in the mouse.
    Rogers K; Barnes AD
    Transplantation; 1974 Apr; 17(4):435-7. PubMed ID: 4595929
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunization with Escherichia coli-produced soluble MHC class I proteins induces accelerated rejection or prolonged survival of rat cardiac allografts.
    Perez J; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1999 May; 31(3):1560. PubMed ID: 10331000
    [No Abstract]   [Full Text] [Related]  

  • 31. B-cell alloantigens determined by the H-2 linked Ir region are associated with mixed lymphocyte culture stimulation.
    Lozner EC; Sachs DH; Shearer GM; Terry WD
    Science; 1974 Feb; 183(4126):757-9. PubMed ID: 4150717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross reactivity between H-2K and H-2D products. III. Effect of H-2K-H-2D cross sensitization on skin graft survival.
    Murphy DB; Shreffler DC
    Transplantation; 1975 Jul; 20(1):38-44. PubMed ID: 52220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival.
    Szot GL; Zhou P; Sharpe AH; He G; Kim O; Newell KA; Bluestone JA; Thistlethwaite JR
    Transplantation; 2000 Mar; 69(5):904-9. PubMed ID: 10755548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential immunogenic expression of an H-2-linked histocompatibility antigen on different tissues. Differences in survival between heart, thyroid, and skin allografts.
    Isakov N; Yankelevich B; Segal S; Feldman M
    Transplantation; 1979 Jul; 28(1):31-5. PubMed ID: 377590
    [No Abstract]   [Full Text] [Related]  

  • 35. The differential destructive and enhancing effects of anti-H-2K, H-2D, and anti-Ia antisera on murine skin allografts.
    McKenzie IF; Henning MM
    J Exp Med; 1978 Feb; 147(2):611-6. PubMed ID: 342669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-gamma alters the pathology of graft rejection: protection from early necrosis.
    Halloran PF; Miller LW; Urmson J; Ramassar V; Zhu LF; Kneteman NM; Solez K; Afrouzian M
    J Immunol; 2001 Jun; 166(12):7072-81. PubMed ID: 11390451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cross-reacting microbial antigens and antibodies on the allograft rejection reaction.
    Ogurtsov RP
    Bull Exp Biol Med; 1974 Nov; 77(5):542-4. PubMed ID: 4613404
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro sensitization to transplantation antigens. II. Role of H-2 antigen and culture supernatant.
    Dyminski JW; Argyris BF
    Transplantation; 1972 Mar; 13(3):229-33. PubMed ID: 4553725
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts.
    Peugh WN; Superina RA; Wood KJ; Morris PJ
    Immunogenetics; 1986; 23(1):30-7. PubMed ID: 3510970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC; Andrews EJ; Basombrío MA; Litwin S; Prehn RT
    J Natl Cancer Inst; 1972 Nov; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.